Home/Filings/4/0000899243-18-009562
4//SEC Filing

Sjogren Eric 4

Accession 0000899243-18-009562

CIK 0001496671other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:06 PM ET

Size

9.6 KB

Accession

0000899243-18-009562

Insider Transaction Report

Form 4
Period: 2018-04-03
Sjogren Eric
SR. VP, DRUG DISCOVERY
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-04-038,2090 total
    Exercise: $0.48Exp: 2021-12-13Common Stock (8,209 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-04-038,6010 total
    Exercise: $0.48Exp: 2022-06-12Common Stock (8,601 underlying)
  • Exercise/Conversion

    Common Stock

    2018-04-03$0.48/sh+16,810$8,06942,818 total
Footnotes (3)
  • [F1]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan each on May 15, 2015, November 13, 2015, May 13, 2016, June 9, 2017 and December 8, 2017. Includes 1,877 shares acquired under the Company's 2014 Employee Stock Purchase Plan on November 15, 2016.
  • [F2]1/48 of the Option vests in equal monthly installments one month from 11/07/2011.
  • [F3]1/48 of the Option vests in equal monthly installments one month from 03/27/2012.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001618119

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:06 PM ET
Size
9.6 KB